UNH Stock Analysis — UnitedHealth Group
Sector: Healthcare
AI Verdict
UNH trades at 20x next year's earnings with nearly 30% growth expected, making it cheap for the growth on offer if its integration moat keeps delivering.
Competitive Moat
UnitedHealth Group combines the largest private health insurance network in the U.S. with Optum's data-driven healthcare services, creating scale and integration advantages that are hard for rivals to replicate. Its proprietary claims data and vertical integration across insurance, pharmacy, and care delivery give it pricing power and cost efficiencies.
Summary
UNH stands out for its vertically integrated insurance and healthcare services model, which is driving strong earnings growth.
Where It Stands
UNH delivered a 34.44% 1-year return and trades at 20.0x next year's earnings, a discount to the healthcare sector median of 22x despite 29.6% forward EPS growth.
Key Metrics
- Trailing P/E: 26.0x
- Forward P/E: 20.0x
- PEG Ratio: 0.86
- Earnings Growth: +0.3%
- 1-Year Return: 34.44%
Analyst Consensus
27 Buy · 7 Hold · 0 Sell (34 analysts) · Target $477.42
Bull Case
With analysts expecting 29.6% EPS growth and a forward P/E of 20.0x, you're paying a low price for outsized earnings expansion.
Bear Case
If the forward P/E reverts to the sector median of 22x without delivering on the 29.6% EPS growth, the upside narrows and any earnings miss could trigger a sharp pullback.
Catalyst to Watch
Watch for quarterly earnings and regulatory updates—any surprise in medical cost trends or policy changes could shift the growth outlook.